When will the vaccine be ready?
If approved for emergency use by the FDA, Pfizer-BioNTech will be able to provide 25 million doses to the United States by the end of the year, while Moderna will have 20 million available. As both drugs require two doses for full inoculation, 22.5 million Americans will be able to be vaccinated initially.
